News

Zetagen Therapeutics, founded 2015, private clinical-stage biopharmaceutical company develops first-of-its-kind targeted ...
AstraZeneca is planting its flag in the oral SERD space, touting positive Phase 3 breast cancer data for a program it expects ...
The CDC will no longer recommend routine Covid-19 vaccines for healthy kids and pregnant women after HHS Secretary Robert F.
Novo Nordisk warned the US government not to impose pharma-specific tariffs, but instead to tax illegal importers of ...
Devoted Health, the Medicare Advantage insurer with a medical group, has laid off about 120 employees. The layoffs, which ...
After a slight delay, the FDA rejected Stealth BioTherapeutics' Barth syndrome drug application for elamipretide, but will ...
Arvinas' vepdegestrant shows 43% reduced risk of progression or death in ESR1-mutated breast cancer patients vs hormone ...
The US Supreme Court will continue deciding whether to take up a pivotal case on state PBM regulation after the federal ...
The Column Group's drug R&D team, known as TCG Labs Soleil, has been busy churning out new portfolio companies since it ...
The companies said Thursday that they voluntarily withdrew the accelerated approval request for patritumab deruxtecan in ...
Strand Therapeutics reports early positive data for STX-001, a self-replicating mRNA cancer therapy, showing safety and ...
Protein degrader shop GlycoEra, spun out of vaccines company LimmaTech in 2021, has corralled $130 million in Series B ...